The Hidden Crisis of the Black Womb: Uterine Health Disparities and Ways to Improve Care

Podcast in a Nutshell

In this episode, Flora Lichtman talks with gynecologic oncologist Dr. Kemi Kamidahl about the stark racial disparities in uterine cancer outcomes, the social and medical factors that contribute to later diagnoses, and practical steps to improve care for Black women. Kamidahl explains the concept of a “terrible strength” carried through generations and how it can mask serious gynecologic symptoms, as well as how her research has challenged prevailing early-diagnosis thresholds and led to updated guidelines that emphasize biopsy earlier in the workup for postmenopausal bleeding. The conversation also addresses the broader links between womb health, reproductive rights, and the health care system.

• Disparities in uterine cancer mortality and care for Black women
• Normalization of severe gynecologic symptoms and clinician bias
• Diagnostic thresholds and the shift toward earlier biopsy in postmenopausal bleeding
• The role of language, reproductive rights, and policy in womb health

Introduction: The Terrible Strength and the Black Womb

The podcast opens with a stark health statistic: Black women are disproportionately affected by uterine cancer and related conditions, with mortality rates higher than white women. Dr. Kemi Kamidahl, a gynecologic oncologist and professor at the University of Washington, explains her mission to transform womb health care and to confront the systemic biases that contribute to worse outcomes. The concept of a "terrible strength" is introduced as an inherited resilience that helps Black women navigate a society not built for them, but which can obscure vulnerability to gynecologic diseases.

"a terrible strength is this inherited, true, powerful ability to endure and to be resilient and to be successful in a society that is not built for you" - Dr. Kamidahl

Kamidahl’s background as a clinician and researcher frames the discussion: understanding not just biology but also the social and medical contexts that shape care for patients with uterine health issues.

Consequences in Clinical Care: Normalization and Misdiagnosis

The conversation moves from statistics to lived experience. Kamidahl describes how Black women often normalize severe symptoms such as heavy bleeding and debilitating pain, delaying care until anemia or other crises occur. She shares a case of a patient whose hemoglobin was 4, a life-threatening level, yet who came in for a routine pap smear. The normalization of severe symptoms interacts with a medical system biased against seeing Black women as vulnerable, leading to misdiagnosis or under-treatment when patients finally seek help.

"the normalization of severe symptoms" - Dr. Kamidahl

Shifting Practice and Research: From Question Framing to Diagnostic Thresholds

Kamidahl discusses how she began changing her clinical approach during training, asking explicitly different questions such as, "how many days a month do you not bleed?" to uncover abnormalities that patients themselves might normalize. She emphasizes that fibroids—particularly prevalent among Black women—are often only treated when highly symptomatic, and that clinicians must look for signs beyond patient-reported suffering. A central topic is the diagnostic workup for postmenopausal bleeding, which historically used a transvaginal ultrasound threshold (endometrial lining thickness) of 4 millimeters to rule out cancer and avoid biopsy. Her research showed this threshold underperforms for Black women, missing about 10% of cancers in that group. This finding helped catalyze a shift in practice and, more recently, updated guidelines from the American College of Obstetricians and Gynecologists to include biopsy earlier in the workup for postmenopausal bleeding.

"10% of Black women with uterine cancer were missed by that threshold" - Dr. Kamidahl

Diagnostics, Bias, and Policy: The Path Forward

The discussion turns to the broader implications of these findings for care across the lifespan of individuals with a uterus. Kamidahl connects womb health to reproductive rights and access to care, arguing that policies restricting certain medications or framing treatments through an exclusively reproductive lens can hinder effective management of lifelong gynecologic conditions. The updated guidelines to biopsy earlier reflect a data-driven approach to closing the diagnostic gap, but Kamidahl calls for ongoing attention to the silences surrounding gynecologic health, the normalization of symptoms, and accountability within patient communities and the health care system alike.

"there is no assault on reproductive freedom and reproductive health care that is siloed and will not impact our ability to provide care for the womb throughout its entire life" - Dr. Kamidahl

Takeaways: Language, Community, and Health Equity

The episode concludes with a call to break silence, establish baselines for what is normal, and foster supportive networks—"womb sisters" with accountability to ensure follow-up care. Kamidahl argues that protecting reproductive health care is essential to providing comprehensive care for the womb throughout life, not just during pregnancy. The discussion closes by tying uterine health to broader health equity and the need for credible, access-friendly policies that support both prevention and treatment for all people with a uterus.

Quotes Recap

“a terrible strength is this inherited, true, powerful ability to endure and to be resilient and to be successful in a society that is not built for you” - Dr. Kamidahl

“the normalization of severe symptoms” - Dr. Kamidahl

“10% of Black women with uterine cancer were missed by that threshold” - Dr. Kamidahl

“there is no assault on reproductive freedom and reproductive health care that is siloed and will not impact our ability to provide care for the womb throughout its entire life” - Dr. Kamidahl